32 The primary outcome for the trial was the first occurrence of a major adverse cardiovascular event (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke)
This leads researchers to assume that there is a heritable component to mastocytosis as well (e.g., other genes involved).[ref][ref] In addition to KIT mutations, systemic mastocytosis also has links to mutations in the JAK2, PDGFR, NRAS, RASGRP4, CBL, IL4, TET2, and IL13 genes.[ref] MicroRNAs are also involved in the regulation of KIT expression.[ref] Interestingly, about half of all kids with cutaneous mastocytosis tend to outgrow it and go into long-term remission
But, you cannot compound just to save money or because it seems easier
[64] found that dulaglutide, a long-lasting form of GLP-1RA administrated once weekly, is also safe and does not increase the risk of major cardiovascular events in patients with T2DM